Yes, Medicare covers Welireg (belzutifan) under the Part D prescription drug benefit, so the question of whether Medicare covers Welireg comes down to your specific Part D plan’s formulary and its prior authorization rules. Because Welireg is a pill you take at home rather than an infusion given in a clinic, it is not a Part B drug. Nearly every Part D plan places it on the specialty tier and requires prior authorization before paying.1Kaiser Permanente. Belzutifan (Welireg) Coverage Criteria
How Part D Coverage Works for Welireg
Welireg is FDA-approved for adults with von Hippel-Lindau disease who need treatment for certain tumors without immediate surgery, for adults with advanced renal cell carcinoma who have already received a PD-1 or PD-L1 immunotherapy and a VEGF tyrosine kinase inhibitor, and for adults and children 12 and older with locally advanced, unresectable, or metastatic pheochromocytoma or paraganglioma.2U.S. Food and Drug Administration. FDA Approves Belzutifan for Advanced Renal Cell Carcinoma3U.S. Food and Drug Administration. FDA Approves Belzutifan for Pheochromocytoma or Paraganglioma
For a Part D plan to approve Welireg, the prescriber generally has to document the patient’s diagnosis, confirm the use matches an FDA-approved indication, and show that any required prior therapies have been tried. For the advanced RCC indication, plans typically ask for evidence that the patient previously received both an immunotherapy drug and a VEGF inhibitor.4Mass General Brigham Health Plan. Welireg Prior Authorization Policy Approvals usually run 12 months, and renewal depends on showing no disease progression or unacceptable side effects.
Medicare can also cover off-label cancer uses when they appear in approved medical compendia such as the NCCN Drugs and Biologics Compendium with a favorable recommendation. A use listed as NCCN Category 1 or 2A, for example, can be treated as medically accepted by Medicare contractors and considered for coverage.5Centers for Medicare & Medicaid Services. Medicare Benefit Policy Manual, Chapter 15
What You Will Pay Out of Pocket in 2026
The list price is steep. Merck’s wholesale acquisition cost for a 90-count bottle of 40 mg tablets is $31,162.50.6Merck. Connecticut Pricing Disclosure for Welireg At that level, a single fill moves a Part D beneficiary through the deductible and into the catastrophic phase almost immediately.
The Inflation Reduction Act changed what that means for the person taking the drug. In 2026, your Part D cost-sharing works in three phases:7Centers for Medicare & Medicaid Services. Final CY 2026 Part D Redesign Program Instructions
- Deductible phase. You pay 100% of covered drug costs until you hit your plan’s deductible, which cannot exceed $615 for 2026.
- Initial coverage phase. You pay 25% coinsurance on covered drugs.
- Catastrophic phase. Once your out-of-pocket spending for the year reaches $2,100, you pay $0 for covered Part D drugs for the rest of the calendar year.8UnitedHealthcare. Part D Changes
The old coverage gap, the “donut hole,” is gone.9National Council on Aging. Who Pays What for Medicare Part D in 2026 For a Welireg patient, the practical result is that your annual out-of-pocket cost for all covered Part D drugs is capped at $2,100.
Spreading the Cost Across the Year
Even $2,100 is hard to absorb in a single January pharmacy visit. Since January 1, 2025, the Medicare Prescription Payment Plan has let beneficiaries pay their Part D cost-sharing in monthly installments instead of at the counter.10Medicare.gov. What’s the Medicare Prescription Payment Plan
Enrollment is voluntary and free. Once you are in, you pay nothing at the pharmacy; your Part D plan bills you monthly, dividing the remaining out-of-pocket costs by the months left in the year. Monthly amounts can change as new prescriptions are filled, but the yearly total still cannot exceed the $2,100 cap.11Medicare.gov. Before You Choose the Medicare Prescription Payment Plan The program does not reduce what you owe; it only reshapes when you pay it. No interest is charged. Enrollment auto-renews, though switching plans means re-enrolling with the new one.12PAN Foundation. Understanding the Medicare Prescription Payment Plan Medicare advises against signing up after September, when too few months remain to meaningfully spread the costs.
Programs That Lower the Cost Further
Extra Help
Medicare’s Extra Help program, also called the Low-Income Subsidy, pushes costs well below the $2,100 cap for people who qualify. In 2026, eligible beneficiaries pay $0 for plan premiums and deductibles and no more than $12.65 per covered brand-name prescription. Once total drug costs reach $2,100 for the year, you pay nothing for the rest of the year.13Medicare.gov. Help With Drug Costs
To qualify in 2026, your monthly income must be at or below $2,015 for an individual or $2,725 for a couple, and you must meet asset limits. People enrolled in Medicaid, Supplemental Security Income, or a Medicare Savings Program qualify automatically.14Medicare Interactive. Extra Help Basics
Charitable Copay Foundations
Manufacturer copay cards are off the table for anyone with Medicare because of federal anti-kickback rules.15Merck. Patient Support Programs Independent charitable foundations fill much of that gap, and several run disease-specific funds that explicitly accept Medicare patients:
- PAN Foundation offers grants of up to $4,400 initially (up to $8,800 per year) for government-insured renal cell carcinoma patients, with Welireg listed as a covered medication. Income must be at or below 500% of the Federal Poverty Level.16PAN Foundation. Renal Cell Carcinoma Fund
- Patient Advocate Foundation Co-Pay Relief provides up to $8,000 per year for RCC patients. PAF and PAN are merging into a combined platform called TotalAssist, expected to go live July 1, 2026.17Patient Advocate Foundation. Renal Cell Carcinoma Fund
- HealthWell Foundation awards up to $10,000 for Medicare-insured RCC patients with income at or below 500% of the Federal Poverty Level.
- CancerCare provides up to $7,000 initially with a $10,000 lifetime cap for kidney cancer patients in active treatment.
- The Assistance Fund covers copayments, coinsurance, deductibles, and other health-related costs for kidney cancer patients.
These funds open and close as donations allow. The PAN Foundation’s free FundFinder tool tracks more than 200 assistance funds across nine organizations and sends alerts when relevant funds reopen. Charitable grants can be stacked with the Medicare Prescription Payment Plan; the grant is applied to the medication cost before your plan calculates the monthly installment.12PAN Foundation. Understanding the Medicare Prescription Payment Plan
Merck’s Hardship Exception
Merck’s standard Patient Assistance Program is for people with no insurance at all, and Medicare counts as insurance. But Medicare beneficiaries who cannot afford their deductible, copay, or coinsurance may apply for a case-by-case Financial Hardship Exception.18Merck. Welireg MAP Enrollment Form Household income must be at or below $79,800 for an individual, $108,200 for a couple, or $165,000 for a family of four, and Merck can request documentation.19Merck Helps. Welireg Patient Assistance
One important catch for Medicare enrollees: medication received through the hardship exception does not count toward your Part D out-of-pocket spending, so it will not push you toward the $2,100 cap. Eligibility also expires every December 31 and requires a fresh application each year.
If Your Plan Denies Welireg
A denial is not the end of the road. The Merck Access Program (855-257-3932, Monday through Friday, 8 a.m. to 8 p.m. ET) helps with prior authorization paperwork and appeal support.20Welireg.com. Access and Support
Medicare’s Part D appeals process has five levels: plan redetermination, reconsideration by an Independent Review Entity, an Administrative Law Judge hearing, Medicare Appeals Council review, and federal court review when the claim meets a minimum dollar threshold.21Patient Advocate Foundation. Medicare Denials and Appeals You have 60 days from each decision to file at the next level. A letter from your doctor explaining why Welireg is medically necessary strengthens the appeal, and your State Health Insurance Assistance Program (SHIP) will walk you through the process at no cost.22Medicare.gov. Medicare Claims, Appeals & Complaints